CHAD Therapeutics Financial Market Data
| Last Close 12-Sep-2008 |
$0.15 |
Price/ Sales Ratio |
-- |
| 52-Week High |
$0.96 |
Price/ Book Ratio |
1.30 |
| 52-Week Low |
$0.03 |
Price/ Earnings Ratio |
0.18 |
| 60-Month Beta |
1.5 |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$1.5 |
Return on Assets |
(112.5%) |
| Shares Outstanding (mil.) |
10.2 |
Return on Equity |
(167.6%) |
| Dividend Rate |
-- |
Current Ratio |
1.15 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
9 |
% Owned by Institutions |
2.0% |
| Latest Short Interest Ratio |
-- |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
0.0% |
0.0% |
0.0% |
| EPS Growth |
0.0% |
372.2% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
